FDA Inspection 1079217 — Carl P. Griffin, M.D.
The FDA completed an inspection of Carl P. Griffin, M.D. on February 1, 2019 in Oklahoma City, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 1, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Oklahoma City, OK (United States)
Additional Details
Clinical Investigator (CI)